News & Insights

rss

Stay informed with the latest MRL, Food Additive and Company news from around the world.


March 20, 2017
N/A

On March 20, Brazil's National Health Surveillance Agency (ANVISA) published amendments for chlorfluazuron, spinetoram, cyproconazole, clethodim, azadirachtin, amicarbazone, azoxystrobin (proposed via Consulta Pública n° 296 and n° 306), halosulfuron-methyl, indaziflam, linuron, mepiquat chloride, propaquizafop, triclopyr, thiodicarb, tebuconazole (proposed via Consulta Pública n° 304 and n° 308), and iodosulfuron-methyl-sodium.

MRL changes from these amendments will be displayed in the Global MRL Database on March 21.

February 10, 2017
N/A

This week, Brazil's National Health Surveillance Agency (ANVISA) published proposed monograph changes (including some MRL revisions) for chlorfluazuron, spinetoram, cyproconazole, clethodim, azadirachtin, amicarbazone, azoxystrobin (Consulta Pública n° 296 and  306), halosulfuron-methyl, indaziflam, linuron, mepiquat chloride, propaquizafop, triclopyr, thiodicarb, tebuconazole (Consulta Pública n° 304 and  308), iodosulfuron-methyl-sodium (links in Portuguese).

Comments on these proposals must be submitted by March 11, 2017 for iodosulfuron-methyl-sodium, azoxystrobin (n° 306), and tebuconazole (n° 308) and by March 10, 2017 for all other active ingredients. Relevant proposed MRLs will display in the Global MRL Database on February 11, 2017.

September 6, 2016
N/A

On September 5, Brazil’s National Health Surveillance Agency (ANVISA) published amendments for pyrimethanil, mancozeb, amicarbazone, diquat, spiromesifen, chlorothalonil, benzyladenine, chlorantraniliprole, imazamox, and ethiprole.

MRL changes from these amendments will display in the Global MRL Database on September 7, 2016.

July 28, 2016
N/A

On July 28, Brazil's National Health Surveillance Agency (ANVISA) published draft amendments proposing changes for the following active ingredients (in Portuguese): amicarbazone, chlorantraniliprole, mancozeb, pyrimethanil, imazamox, spiromesifen, chlorothalonil, and benzyladenine.

Comments on these proposals must be submitted by August 26, 2016. Relevant proposed MRLs will show in the Global MRL Database on July 29.

All News Tags